📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study. (2020)

First Author: Cresswell FV

Attributed to: High Dose Oral Rifampicin to Improve Survival from Adult TB Meningitis - (HARVEST) Trial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(19)30550-x

PubMed Identifier: 31924549

Publication URI: http://europepmc.org/abstract/MED/31924549

Type: Journal Article/Review

Volume: 20

Parent Publication: The Lancet. Infectious diseases

Issue: 3

ISSN: 1473-3099